Skip to content
No results
Home
About
Executive Team
Board of Directors
Stategic Collaborations
Careers
Products
Zabadinostat (CXD101)
AT-101
PCV-001
Press Releases
Pipeline
Publications
Contact
Home
About
Executive Team
Board of Directors
Stategic Collaborations
Careers
Products
Zabadinostat (CXD101)
AT-101
PCV-001
Press Releases
Pipeline
Publications
Contact
Search
Menu
ASH Dec 16 Poster 1
December 10, 2016
ASH-Dec-2016-Poster-1
Share This Post
X
Facebook
LinkedIn
Messenger
WhatsApp
Posts navigation
← Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2)
ASH Dec 16 Poster 2 →
More Posts
IngenOx Therapeutics Company Update and Board Reshuffle
May 10, 2024
IngenOx Therapeutics Contributes to Review of Diagnostic Biomarkers for Precision Bowel Cancer Adjuvant Therapy
December 7, 2023
IngenOx Therapeutics Receives Granted Patents from the EU and China for PRMT5 Inhibitor-based Drugs.
October 6, 2023
